Welcome to our dedicated page for McKesson news (Ticker: MCK), a resource for investors and traders seeking the latest updates and insights on McKesson stock.
McKesson Corporation (NYSE: MCK) is a diversified healthcare services and pharmaceutical distribution company that regularly issues news and updates relevant to investors, healthcare partners, and other stakeholders. The company describes itself as dedicated to advancing health outcomes for patients everywhere, partnering with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services that support access to quality care.
The McKesson news feed typically features announcements about quarterly and annual financial results, earnings release dates, and related investor webcasts. These updates often include information about fiscal guidance, long-term financial targets, and commentary on strategic priorities and business outlook shared during events such as Investor Day.
In addition to earnings and guidance, McKesson’s news includes Board actions such as dividend declarations, reflecting decisions on returning capital to shareholders. The company also issues releases on organizational and segment reporting changes, including the introduction of its North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions segments, along with portfolio developments like planned separations or divestitures.
McKesson may also appear in third-party announcements highlighting distribution agreements and collaborations that illustrate its role in pharmaceutical distribution and healthcare services. Such items can show how McKesson supports access to therapies through its distribution networks and healthcare supply chain capabilities.
For readers tracking MCK news, this page provides a centralized view of financial announcements, strategic updates, capital allocation decisions, and partnership-related developments. Regularly reviewing these items can help investors and observers understand how McKesson communicates its performance, segment evolution, and strategic focus within the healthcare and wholesale trade landscape.
McKesson (NYSE: MCK) announced a strategic reorganization of its reportable segments, effective Q2 FY2026. The company will restructure into four main segments: North American Pharmaceutical, Oncology and Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.
The reorganization aims to enhance strategic focus on high-margin areas including oncology, multispecialty, and biopharma services. Notably, McKesson plans to separate its Medical-Surgical Solutions segment into an independent company, as announced in May 2025. Additionally, the company has entered into an agreement to sell its Norwegian operations, subject to regulatory approvals.
The company will provide additional details during its upcoming Investor Day on September 23, 2025.
McKesson Corporation (NYSE: MCK) has announced the release of its fiscal 2026 first quarter financial results. The company will host a live earnings conference call for investors on August 6, 2025, at 4:30 PM ET to discuss the quarterly performance.
Investors can access the financial results, earnings press release, financial tables, and slide presentation on McKesson's Investor Relations website. The audio webcast of the conference call will be available both live and archived at investor.mckesson.com/financials/quarterly-results.
McKesson Corporation (NYSE:MCK) has announced a 15% increase in its quarterly dividend to $0.82 per share from $0.71 per share. The dividend will be payable on October 1, 2025, to stockholders of record on September 2, 2025.
This marks McKesson's ninth consecutive annual dividend increase, demonstrating the company's commitment to returning capital to shareholders. CEO Brian Tyler emphasized that this decision reflects confidence in the company's business strength and dedication to creating long-term shareholder value.
McKesson Corporation (NYSE: MCK) has announced it will release its first quarter fiscal 2026 financial results after market close on Wednesday, August 6, 2025. The company will host a live webcast earnings conference call for investors at 4:30 PM Eastern Time to discuss the financial results. Both the live and archived versions of the audio webcast will be accessible through McKesson's Investor Relations website.
Summary not available.
McKesson (NYSE: MCK) has completed its acquisition of a controlling interest in PRISM Vision Holdings, a leading provider of ophthalmology and retina management services. The transaction values at approximately $850 million for an 80% stake, while PRISM physicians retain the remaining 20% interest.
The strategic acquisition aims to establish McKesson as a leading platform in retinal and ophthalmology services, enhancing its differentiated value proposition, clinical services, and distribution offerings. The company also announced it will release its fourth quarter and full year fiscal 2025 financial results after market close on May 8, 2025, followed by an earnings conference call at 4:30 PM Eastern Time.
McKesson (NYSE: MCK) has announced its financial results for the third quarter of fiscal year 2025. The company has also raised its full-year adjusted EPS guidance. The detailed financial results are available on McKesson's Investor Relations website. The company is hosting a live webcast earnings conference call on February 5th at 4:30 PM ET to discuss the results with investors. The webcast, earnings release, financial tables, and presentation slides will be accessible on McKesson's Investor Relations platform.